PUXEDDU, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 20.115
NA - Nord America 3.777
AS - Asia 1.525
SA - Sud America 171
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 2
Totale 25.624
Nazione #
IT - Italia 19.214
US - Stati Uniti d'America 3.747
SG - Singapore 655
CN - Cina 586
UA - Ucraina 338
SE - Svezia 167
BR - Brasile 130
FI - Finlandia 124
VN - Vietnam 106
DE - Germania 86
FR - Francia 78
GB - Regno Unito 55
HK - Hong Kong 38
KR - Corea 31
IN - India 26
BD - Bangladesh 19
CA - Canada 19
EU - Europa 14
IQ - Iraq 14
AR - Argentina 13
RU - Federazione Russa 13
NL - Olanda 11
CO - Colombia 10
ZA - Sudafrica 9
VE - Venezuela 7
ES - Italia 6
PS - Palestinian Territory 6
DZ - Algeria 5
JP - Giappone 5
PH - Filippine 5
ID - Indonesia 4
MX - Messico 4
MY - Malesia 4
PK - Pakistan 4
TH - Thailandia 4
AZ - Azerbaigian 3
CL - Cile 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
MA - Marocco 3
PL - Polonia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
KE - Kenya 2
MD - Moldavia 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TO - Tonga 1
Totale 25.624
Città #
Cagliari 18.931
Fairfield 443
Woodbridge 397
Ashburn 330
Singapore 304
Houston 267
Chandler 251
Jacksonville 183
Dallas 176
Ann Arbor 166
Seattle 166
Wilmington 166
Uta 156
Cambridge 147
Boardman 145
San Jose 134
Beijing 130
Nyköping 120
Nanjing 70
Helsinki 64
Santa Clara 57
Dearborn 54
Los Angeles 54
Lauterbourg 53
Boston 47
Hefei 44
Ho Chi Minh City 35
Hong Kong 35
Seoul 31
Shanghai 30
The Dalles 27
Hanoi 25
Nanchang 25
Buffalo 23
San Diego 18
Shenyang 18
Redondo Beach 17
Hebei 15
Changsha 13
Toronto 13
Milan 11
Norwalk 11
São Paulo 11
Jiaxing 10
Jinan 10
Tianjin 10
Kunming 9
New York 9
Baghdad 8
Guangzhou 8
Stockholm 8
Turku 8
Da Nang 7
Frankfurt am Main 7
Monsummano Terme 7
Ningbo 7
Rio de Janeiro 7
Verona 7
Brasília 6
London 6
Mountain View 6
Zhengzhou 6
Council Bluffs 5
Dhaka 5
Haiphong 5
Johannesburg 5
Medellín 5
Millbury 5
Munich 5
Phoenix 5
San Francisco 5
Serra 5
Tokyo 5
Washington 5
Augusta 4
Chennai 4
Chicago 4
Curitiba 4
Dong Ket 4
Düsseldorf 4
Meppel 4
Algiers 3
Baku 3
Belo Horizonte 3
Campinas 3
Caracas 3
Columbus 3
Pune 3
Ramallah 3
Redwood City 3
Saint Petersburg 3
Santiago de los Caballeros 3
Thái Bình 3
Uberlândia 3
Warsaw 3
West Jordan 3
Atlanta 2
Belgrade 2
Brindisi 2
Brooklyn 2
Totale 23.700
Nome #
Salivary gland pathology in IgG4-related disease: A comprehensive review 2.120
Parotid mass as an early sign of Kaposi's sarcoma associated with human herpesvirus 8 infection 1.052
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis 713
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases 707
Effect of rheumatoid arthritis (RA) susceptibility genes on the immune response to viral citrullinated peptides in RA 663
Angiogenesis in spondyloarthritis: target for new diagnostic approaches 655
Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts 654
Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant 652
Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab 651
Defective epithelial barrier function in asthma 641
Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis. 635
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria 635
Two Takayasu arteritis patients successfully treated with rituximab. 627
CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria 609
Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. 590
Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and relation with anti-CCP and anti-VCP1 588
CCL5/RANTES in ANCA-associated small vessel vasculitis 565
HLA Shared Epitope and ACPA: just a marker or an active player? 561
Cell surface expression of Activiting Receptors and co-receptors on peripheral blood NK cells in mixed cryoglobulinemia 557
The endogenous angiostatic mediators endostatin and thrombospondin-1 are increased in spondyloarthritis 535
Mycophenolic acid suppresses human pterygium and normal tenon fibroblast proliferation in vitro. 506
Osteopontin is expressed and functional in human eosinophils 497
Mast cells and Eosinophils: a novel link between inflammation and angiogenesis in allergic diseases 400
Mast cells and eosinophils: the hallmark of asthma 394
Human Mast Cells release Oncostatin M on contact with activated T cells: possible biologic relevance 386
Nerve Growth Factor effect on human primary fibroblstic-kerstocyte: possible mechanism during corneal healing 384
The pro-fibrogenic effect of Nerve Growth Factor on conjunctival fibroblasts is mediated by transforming growth factor beta 380
Effects of dexamethasone on TNF-alpha-induced release of cytokines from purified human blood eosinophils 372
The CC-chemokine Eotaxin/CCL11 has a selective pro-fibrogenic effect on human lung fibroblasts 363
Hypoxia modulates human eosinophils signalling and function 361
Osteopontin (Opn) is expressed and functional in human peripheral blood eosinophils 353
Angiogenesis in asthma. 352
Eotaxin-1/CCL11 and Eotaxin-2/CCL24 expression and eosinophilic airway inflammation in OVA-challenged BALB/c mice 346
The solubile form of a disintegrin and metalloprotease 33 promotes angiogenesis: Implications for airway remodeling in asthma 345
Human peripheral blood eosinophils induce angiogenesis 337
Mast cells induce activation of human lung fibroblasts in vitro 328
Enhanced osteopontin expression in a murine model of allergen-induced airway remodeling. 324
Eosinophil-derived Major Basic Protein induces angiogenesis 324
Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. 322
Nerve growth factor-a neurotrophin with angiogenic activity 309
Immune effector cells: mast cells and eosinophils? 303
Nerve Growth factor and eosinophils in inflamed juvenile conjunctival nevus 300
Nerve Growth Factor (NGF) activates conjunctival myofibroblasts: a role for NGF in healing process and tissue remodeling 298
Human mast cells release oncostain (OSM) specifically on contact with activated T cells 295
New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis 294
Osteopontin is expressed in human peripheral blood eosinophils and contributes to their pro-angiogenic activity 288
Human cord blood-derived mast cells adhere to extracellular matrix proteins by functional alpha 4 beta 1 (CD49d/CD29), alpha 5 beta 1 (CD49e/CD29), alpha 4 beta 7 integrins and CD44 284
Fibrosis in ocular allergic inflammation – recent concepts in the pathogenesis of ocular allergy 278
Mast cells in allergy and beyond 277
Nerve Growth Factor (NGF) modulates in vitro cultured human derived keratocyte activities: a potential collaborative effect with TGF-neta 1 274
Inhaled corticosteroids modulate eosinophil pro-fibrogenic effects in childhood asthma. 263
Mast cells in tissue remodelling 258
Role of eosinophils in angiogenesis 236
Suppression of fibrotic responses by mycophenolic acid in human tenon fibroblasts in vitro 220
Totale 25.661
Categoria #
all - tutte 42.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021485 0 0 0 0 0 0 0 0 0 213 159 113
2021/2022679 63 76 39 52 30 48 39 74 53 39 55 111
2022/20231.496 118 114 84 108 94 210 49 436 94 56 73 60
2023/20241.877 164 95 124 193 247 155 116 145 107 204 147 180
2024/20251.554 97 105 255 120 207 146 111 58 161 90 109 95
2025/20261.690 176 99 321 138 170 110 353 65 140 118 0 0
Totale 25.661